492 related articles for article (PubMed ID: 33925063)
1. Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.
Kabir MT; Uddin MS; Jeandet P; Emran TB; Mitra S; Albadrani GM; Sayed AA; Abdel-Daim MM; Simal-Gandara J
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925063
[TBL] [Abstract][Full Text] [Related]
2. Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances.
Rahman MA; Dash R; Sohag AAM; Alam M; Rhim H; Ha H; Moon IS; Uddin MJ; Hannan MA
Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33804766
[TBL] [Abstract][Full Text] [Related]
3. New Drugs from Marine Organisms in Alzheimer's Disease.
Russo P; Kisialiou A; Lamonaca P; Moroni R; Prinzi G; Fini M
Mar Drugs; 2015 Dec; 14(1):5. PubMed ID: 26712769
[TBL] [Abstract][Full Text] [Related]
4. Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease.
Olasehinde TA; Olaniran AO; Okoh AI
Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31731422
[TBL] [Abstract][Full Text] [Related]
5. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
6. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
Kwon Y
Exp Gerontol; 2017 Sep; 95():39-43. PubMed ID: 28528007
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.
Siddiqui A; Shah Z; Jahan RN; Othman I; Kumari Y
Biomed Pharmacother; 2021 Dec; 144():112250. PubMed ID: 34607104
[TBL] [Abstract][Full Text] [Related]
9. Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs.
Zhang XZ; Qian SS; Zhang YJ; Wang RQ
Pharm Biol; 2016; 54(1):18-24. PubMed ID: 25857808
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
[TBL] [Abstract][Full Text] [Related]
11. Marine-Derived Compounds with Anti-Alzheimer's Disease Activities.
Hafez Ghoran S; Kijjoa A
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436249
[TBL] [Abstract][Full Text] [Related]
12. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A
Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021
[TBL] [Abstract][Full Text] [Related]
13. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
[TBL] [Abstract][Full Text] [Related]
14. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
Choi DY; Choi H
Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
[TBL] [Abstract][Full Text] [Related]
15. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
16. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
Hölscher C
Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of Marine Molecules to Manage Alzheimer's Disease.
Silva M; Seijas P; Otero P
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34203244
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T; Garner B; Cheng D
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):142-160. PubMed ID: 27471947
[TBL] [Abstract][Full Text] [Related]
19. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
20. Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease.
Castaneda A; Ferraz R; Vieira M; Cardoso I; Vasconcelos V; Martins R
Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34208482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
